Åke Borg
181 – 190 of 394
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer.
(
- Contribution to journal › Article
-
Mark
Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation in BRCA1 or BRCA2.
(
- Contribution to journal › Article
-
Mark
Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
(
- Contribution to journal › Article
-
Mark
Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
(
- Contribution to journal › Article
-
Mark
Genetic profiles distinguish different types of hereditary ovarian cancer.
(
- Contribution to journal › Article
- 2009
-
Mark
Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck
(
- Contribution to journal › Article
-
Mark
A Comprehensive Model for DNA Repair Genes and Radiation in Second Breast Cancers: The WECARE Collaborative Study Group
2009) 18th Annual Meeting of the International-Genetic-Epidemiology-Society In Genetic Epidemiology 33(8). p.189-189(
- Contribution to journal › Published meeting abstract
-
Mark
CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth
(
- Contribution to journal › Article
-
Mark
Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1
(
- Contribution to journal › Article
-
Mark
IDENTIFICATION OF NOVEL SECRETED TUMOR STROMA-DERIVED STIMULATORS OF PROSTATE CANCER GROWTH
2009) 7th International Symposium on Targeted Anticancer Therapies In Annals of Oncology 20(Suppl 3). p.34-34(
- Contribution to journal › Published meeting abstract